Application of bifidobacterium lactis JYBR-190 in product for removing heavy metals in body

Abstract

The invention provides an application of bifidobacterium lactis JYBR-190 in a product for removing heavy metals in a body. The Bifidobacterium lactis JYBR-190 is preserved in the China General Microbiological Culture Collection Center (CGMCC) on July 8, 2019, the address is No.3, yard 1, Beichen West Road, Chaoyang District, Beijing, the postal code is 100101, and the preservation number is CGMCC NO.18092. The strain JYBR-190 belongs to probiotics and has the advantages of high efficiency, safety and no toxic or side effect when being applied to elimination of vivotoxin by adjusting the balance of human flora.

Description

technical field [0001] The invention relates to the technical field of biological applications, in particular to the application of bifidobacterium lactis JYBR-190 in products for eliminating heavy metals in the body. Background technique [0002] Heavy metals are a class of metal elements that are seriously harmful to the human body, and can cause serious damage to the tissues, organs and nervous system of the body. Studies have shown that excessive blood lead can cause fetal / infant / children's nervous system and mental development to be blocked. Significant decline in IQ. The heavy metal element arsenic exists widely in the surface, water, atmosphere, soil, food and living organisms in the form of compounds; mercury can exist in the body in the form of ions, which leads to digestive disorders in the body, a decrease in the absorption rate of food, and weight loss; in addition Mercury can also flow through the whole body along with the blood circulation, and accumulate in t...

AI Technical Summary

Problems solved by technology

[0003] The drugs currently used to treat lead poisoning are mainly chelating lead repellents, such as: sodium dimercaptosuccinate (NaDMS), calcium sodium edetate (NaDMS), 2 Ca-EDTA), Ca-DTPA, etc. The principle of action of chelating lead-dispelling agents is to form coordination compounds through sulfhydryl or carboxyl groups to achieve the purpose of lead-dispelling. However, these drugs have certain limitations in clinical application. Side effects, such as the low detoxification rate after long-term use of calcium sodium edetate, and some patients may experience transient dizziness, joint pain, abdominal pain, nausea, fatigue and other symptoms; when used in large doses, patients may experience damage such as renal tubular edema

The current clinical treatment of acute mercury poisoning generally uses the metal ion chelating agent dimercaptopropanesulfonate (DMPS). Although this drug can combine with mercury ions, it also binds Ca in the body 2+ , Zn 2+ and other beneficial metal ions, resulting in the loss of beneficial metal ions in the body, resulting in an imbalance in the steady state of metal ions, which in turn affects health; the most commonly used arsenic-expelling drugs in clinical treatment are sulfhydryl drugs, but this drug requires hospitalization when used. Moreover, the drug has many adverse reactions, so many patients with arsenic poisoning cannot actively carry out arsenic depletion treatment

[0004] Microorganisms in the body are a balanced and stable ecosystem. After heavy metals enter the human body, they will inhibit the growth and reproduction of microorganisms, causing the metabolism of the human body to be disordered. Although drug treatment has a certain improvement effect, it will inevitably produce toxic and side effects on the human body. , therefore, with the enhancement of people's health awareness, the attention to the safety of drug use is also increasing. Therefore, it is of great significance to provide a kind of therapeutic drug that is cheap, efficient, has no adverse reactions and can be applied to most patients

Images